Recent Blog Articles

Harvard Health Blog

Baloxavir (Xofluza): A new antiviral drug for the flu

January 2, 2019

About the Author

photo of Daniel Kuritzkes, MD

Daniel Kuritzkes, MD, Contributor

Daniel R. Kuritzkes, MD received his BS and MS degrees in Molecular Biophysics and Biochemistry from Yale University, and his MD from Harvard Medical School. He completed his clinical and research training in internal medicine and … See Full Bio
View all posts by Daniel Kuritzkes, MD


As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.

No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.

Free Healthbeat Signup

Get the latest in health news delivered to your inbox!